New Infectious Disease Analytics Platform Speeds Up Clinical Decision-Making at POC

During the COVID-19 pandemic, the importance of accurate and timely interpretation of diagnostic data became evident in shaping both public health strategies and clinical outcomes. As the world now grapples with more complex challenges like antimicrobial resistance, viral mutations, and co-infections, turning diagnostic data into actionable insights has become essential for clinical advancement and a key component of global health security. A new infectious disease analytics platform that integrates diagnostic results with advanced statistical modeling is now set to transform how outbreaks are detected, monitored, and addressed.

Seegene (Seoul, South Korea) has launched STAgora, a next-generation real-time infectious disease intelligence system that supports clinical decision-making and enhances pandemic preparedness. STAgora offers real-time visualization of infectious disease patterns across municipal, national, and continental levels, grounded in actual diagnostic test data. It delivers structured diagnostic reports and statistical summaries in a clear and actionable format, complete with customizable dashboards and real-time alert features. Beyond tracking individual cases, the platform also allows users to observe outbreaks in specific local or global regions, enhancing visibility into disease dynamics and enabling timely public health responses based on up-to-date information.

By delivering real-time epidemiological data to national and international health agencies, the platform is poised to strengthen public health decision-making and support the creation of effective response plans for widespread disease outbreaks. STAgora includes over 40 integrated statistical tools that facilitate early identification of unusual pathogen activity and assist in modeling seasonal patterns and emerging outbreaks. These tools cover a wide range of functions, such as monitoring individual infections, analyzing co-infections based on symptoms, and calculating real-time trends in infection rates. Together, they convert static diagnostic information into predictive intelligence that informs proactive healthcare strategies. In contrast to traditional surveillance systems that depend on delayed data, STAgora provides immediate analysis of PCR-derived diagnostics, offering real-time tracking of pathogen spread and AI-powered forecasts of potential outbreaks.

When used alongside Seegene’s proprietary syndromic quantitative PCR technology, STAgora gives a comprehensive view of both single-pathogen and multi-pathogen co-infections. This robust diagnostic perspective allows clinicians to make faster, more precise decisions at the point of care. With STAgora, Seegene aims to build the foundation of a more agile and interconnected global health defense network. The platform’s combination of real-time molecular testing, AI-driven analytics, and global data sharing marks a strategic move toward a smarter public health infrastructure. Seegene envisions STAgora as a core component of the international infectious disease response system, setting a new benchmark in diagnostic intelligence and preparedness.

Related Links:
Seegene